Inflammation in Renal Diseases: New and Old Players

Carregando...
Imagem de Miniatura
Citações na Scopus
201
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
ANDRADE-OLIVEIRA, Vinicius
WATANABE, Ingrid Kazue Mizuno
Citação
FRONTIERS IN PHARMACOLOGY, v.10, article ID 1192, 19p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Inflammation, a process intimately linked to renal disease, can be defined as a complex network of interactions between renal parenchymal cells and resident immune cells, such as macrophages and dendritic cells, coupled with recruitment of circulating monocytes, lymphocytes, and neutrophils. Once stimulated, these cells activate specialized structures such as Toll-like receptor and Nod-like receptor (NLR). By detecting danger-associated molecules, these receptors can set in motion major innate immunity pathways such as nuclear factor kappa B (NF-kappa B) and NLRP3 inflammasome, causing metabolic reprogramming and phenotype changes of immune and parenchymal cells and triggering the secretion of a number of inflammatory mediators that can cause irreversible tissue damage and functional loss. Growing evidence suggests that this response can be deeply impacted by the crosstalk between the kidneys and other organs, such as the gut. Changes in the composition and/or metabolite production of the gut microbiota can influence inflammation, oxidative stress, and fibrosis, thus offering opportunities to positively manipulate the composition and/or functionality of gut microbiota and, consequentially, ameliorate deleterious consequences of renal diseases. In this review, we summarize the most recent evidence that renal inflammation can be ameliorated by interfering with the gut microbiota through the administration of probiotics, prebiotics, and postbiotics. In addition to these innovative approaches, we address the recent discovery of new targets for drugs long in use in clinical practice. Angiotensin II receptor antagonists, NF-kappa B inhibitors, thiazide diuretics, and antimetabolic drugs can reduce renal macrophage infiltration and slow down the progression of renal disease by mechanisms independent of those usually attributed to these compounds. Allopurinol, an inhibitor of uric acid production, has been shown to decrease renal inflammation by limiting activation of the NLRP3 inflammasome. So far, these protective effects have been shown in experimental studies only. Clinical studies will establish whether these novel strategies can be incorporated into the arsenal of treatments intended to prevent the progression of human disease.
Palavras-chave
inflammation, chronic kidney disease (CKD), NF- kappa B, gut microbiota, acute kidney injury (AKI)
Referências
  1. Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
  2. Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020
  3. Aguilar-Toala JE, 2018, TRENDS FOOD SCI TECH, V75, P105, DOI 10.1016/j.tifs.2018.03.009
  4. Arias SCA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056215
  5. Aliasgharzadeh A, 2015, BRIT J NUTR, V113, P321, DOI 10.1017/S0007114514003675
  6. Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077
  7. Amano MT, 2018, INT IMMUNOPHARMACOL, V64, P151, DOI 10.1016/j.intimp.2018.08.020
  8. Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440
  9. Andersen K, 2017, J AM SOC NEPHROL, V28, P76, DOI 10.1681/ASN.2015111285
  10. Andrade-Oliveira V, 2015, J AM SOC NEPHROL, V26, P1877, DOI 10.1681/ASN.2014030288
  11. Andrade-Oliveira V, 2012, TRANSPLANTATION, V94, P589, DOI 10.1097/TP.0b013e31825db680
  12. Andrade-Silva M, 2018, CLIN SCI, V132, P1725, DOI 10.1042/CS20170262
  13. Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
  14. Avila VF, 2019, HYPERTENS RES, V42, P779, DOI 10.1038/s41440-019-0226-6
  15. Awad AS, 2009, KIDNEY INT, V75, P689, DOI 10.1038/ki.2008.648
  16. BAKRIS GL, 1990, AM J PHYSIOL, V258, pF115
  17. Bammens B, 2003, KIDNEY INT, V64, P2196, DOI 10.1046/j.1523-1755.2003.00314.x
  18. Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218
  19. Biehl LM, 2018, INFECTION, V46, P871, DOI 10.1007/s15010-018-1190-9
  20. Bindels LB, 2015, NAT REV GASTRO HEPAT, V12, P303, DOI 10.1038/nrgastro.2015.47
  21. Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028
  22. Braga TT, 2018, INFLAMMOPHARMACOLOGY, V26, P403, DOI 10.1007/s10787-017-0317-4
  23. Braga TT, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00845
  24. Braga TT, 2017, SCI REP-UK, V7, DOI 10.1038/srep39884
  25. Braga TT, 2016, IMMUN INFLAMM DIS, V4, P300, DOI 10.1002/iid3.114
  26. Braga TT, 2012, MOL MED, V18, P1231, DOI 10.2119/molmed.2012.00131
  27. Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161
  28. Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
  29. Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200
  30. Campanholle G, 2010, INFLAMM RES, V59, P861, DOI 10.1007/s00011-010-0198-0
  31. Camps J, 2014, ADV EXP MED BIOL, V824, P1, DOI 10.1007/978-3-319-07320-0_1
  32. Canale D, 2011, HYPERTENS RES, V34, P693, DOI 10.1038/hr.2011.4
  33. Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
  34. Cao Q, 2016, J AM SOC NEPHROL, V27, P1344, DOI 10.1681/ASN.2015030229
  35. Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271
  36. Castoldi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037584
  37. Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111
  38. Chanyi RM, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117708712
  39. Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243
  40. Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208
  41. Chen CB, 2017, CELL PHYSIOL BIOCHEM, V41, P2447, DOI 10.1159/000475914
  42. Chiavaroli L, 2015, EUR J CLIN NUTR, V69, P761, DOI 10.1038/ejcn.2014.237
  43. Chmielewska A, 2010, WORLD J GASTROENTERO, V16, P69, DOI 10.3748/wjg.v16.i1.69
  44. Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541
  45. Correa-Costa M, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/291024
  46. Correa-Costa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049569
  47. Correa-Costa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029004
  48. de Paiva VN, 2009, INT IMMUNOPHARMACOL, V9, P668, DOI 10.1016/j.intimp.2008.11.012
  49. den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213
  50. Deng B, 2017, KIDNEY INT, V92, P89, DOI 10.1016/j.kint.2017.01.009
  51. Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043
  52. Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304
  53. Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107
  54. Dong X, 2007, KIDNEY INT, V71, P619, DOI 10.1038/sj.ki.5002132
  55. Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06
  56. Perez-Cobas AE, 2013, GUT, V62, P1591, DOI [10.1136/gutjnl-2012-303184, 10.4161/gmic.27128]
  57. Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5
  58. Esteban V, 2003, KIDNEY INT, V64, pS33, DOI 10.1046/j.1523-1755.64.s86.7.x
  59. Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303
  60. Fanelli C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02915-6
  61. Faustino VD, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180762
  62. FLOEGE J, 1992, KIDNEY INT, V41, P297, DOI 10.1038/ki.1992.42
  63. Foresto-Neto O, 2018, LAB INVEST, V98, P773, DOI 10.1038/s41374-018-0029-4
  64. Francescato HDC, 2007, TOXICOLOGY, V230, P64, DOI 10.1016/j.tox.2006.10.025
  65. Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611
  66. Fujihara CK, 2005, KIDNEY INT, V67, P1913, DOI 10.1111/j.1523-1755.2005.00290.x
  67. Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF92, DOI 10.1152/ajprenal.00184.2006
  68. Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF1810, DOI 10.1152/ajprenal.00521.2006
  69. Gamboa JL, 2012, J AM SOC NEPHROL, V23, P334, DOI 10.1681/ASN.2011030287
  70. Gao B, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0150-9
  71. Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059
  72. Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2
  73. Gilbert RE, 1999, AM J PATHOL, V155, P429, DOI 10.1016/S0002-9440(10)65139-5
  74. Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016
  75. Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210
  76. Goncalves ARR, 2004, AM J PHYSIOL-RENAL, V286, pF945, DOI 10.1152/ajprenal.00238.2003
  77. Grafe M, 1997, CIRC RES, V81, P804
  78. Griffin KA, 2006, CLIN J AM SOC NEPHRO, V1, P1054, DOI 10.2215/CJN.02231205
  79. Guida B, 2014, NUTR METAB CARDIOVAS, V24, P1043, DOI 10.1016/j.numecd.2014.04.007
  80. Halkjaer SI, 2018, GUT, V67, P2107, DOI 10.1136/gutjnl-2018-316434
  81. Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13
  82. Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507
  83. HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0
  84. Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4
  85. Heymann F, 2009, J CLIN INVEST, V119, P1286, DOI 10.1172/JCI38399
  86. Hida M, 1996, NEPHRON, V74, P349, DOI 10.1159/000189334
  87. Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66
  88. Hisada Y, 1999, J CLIN INVEST, V103, P627, DOI 10.1172/JCI2454
  89. Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5
  90. Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7
  91. Hughes-Large JM, 2014, ATHEROSCLEROSIS, V237, P696, DOI 10.1016/j.atherosclerosis.2014.10.090
  92. Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
  93. Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106
  94. Jang HR, 2009, AM J PHYSIOL-RENAL, V297, pF1457, DOI 10.1152/ajprenal.90769.2008
  95. Jerke U, 2015, KIDNEY INT, V88, P764, DOI 10.1038/ki.2015.159
  96. Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3
  97. Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007
  98. Jo SK, 2006, NEPHROL DIAL TRANSPL, V21, P1231, DOI 10.1093/ndt/gfk047
  99. JOHNSON RJ, 1992, HYPERTENSION, V19, P464, DOI 10.1161/01.HYP.19.5.464
  100. Jones JM, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-34
  101. KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251
  102. Kalantar-Zadeh K, 2002, J RENAL NUTR, V12, P17, DOI 10.1053/jren.2002.29598
  103. Kang DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0225-7
  104. Karasawa K, 2015, J AM SOC NEPHROL, V26, P896, DOI 10.1681/ASN.2014020195
  105. Kawakami T, 2013, J IMMUNOL, V191, P3358, DOI 10.4049/jimmunol.1300342
  106. Kayabasi H, 2013, EUR REV MED PHARMACO, V17, P235
  107. Kim HJ, 2013, J PHARMACOL EXP THER, V346, P465, DOI 10.1124/jpet.113.205732
  108. Kim SM, 2015, AM J PHYSIOL-RENAL, V308, pF993, DOI 10.1152/ajprenal.00637.2014
  109. Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108
  110. Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160
  111. Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105
  112. Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746
  113. Kostylina G, 2008, CELL DEATH DIFFER, V15, P134, DOI 10.1038/sj.cdd.4402238
  114. Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x
  115. Krishnamurthy VMR, 2012, KIDNEY INT, V81, P300, DOI 10.1038/ki.2011.355
  116. Kristensen NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0300-5
  117. Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106
  118. Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523
  119. Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452
  120. Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200
  121. Lee FTH, 2004, J AM SOC NEPHROL, V15, P2139, DOI 10.1097/01.ASN.0000135055.61833.A8
  122. Lee H, 2010, KIDNEY INT, V78, P1100, DOI 10.1038/ki.2010.139
  123. Lee JW, 2019, NEPHROL DIAL TRANSPL, V34, P1481, DOI 10.1093/ndt/gfy370
  124. Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615
  125. Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704
  126. Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832
  127. Leliefeld PHC, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1250-4
  128. LEMLEY KV, 1991, KIDNEY INT, V39, P370, DOI 10.1038/ki.1991.49
  129. Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303
  130. LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004
  131. Li JH, 2018, MOL THER, V26, P2523, DOI 10.1016/j.ymthe.2018.07.014
  132. Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086
  133. Lin CS, 2012, INT J CARDIOL, V156, P41, DOI 10.1016/j.ijcard.2010.10.033
  134. Liu J, 2014, J CLIN INVEST, V124, P1242, DOI 10.1172/JCI72126
  135. Liu LL, 2012, AM J NEPHROL, V36, P386, DOI 10.1159/000343283
  136. Liu P, 2015, CLIN ENDOCRINOL, V83, P475, DOI 10.1111/cen.12673
  137. Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y
  138. Lopez-Franco O, 2006, ARTERIOSCL THROM VAS, V26, P1864, DOI 10.1161/01.ATV.0000229659.94020.53
  139. Lu LH, 2008, J PHARMACOL EXP THER, V324, P111, DOI 10.1124/jpet.107.130161
  140. Machado FG, 2008, AM J PHYSIOL-RENAL, V294, pF1345, DOI 10.1152/ajprenal.00020.2008
  141. MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956
  142. Makkawi S, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000459
  143. Maravitsa P, 2016, IMMUNOL LETT, V178, P68, DOI 10.1016/j.imlet.2016.08.002
  144. Marques VP, 2006, NEPHRON EXP NEPHROL, V104, pE48, DOI 10.1159/000093676
  145. Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729
  146. Martina MN, 2016, J AM SOC NEPHROL, V27, P1113, DOI 10.1681/ASN.2014121214
  147. Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046
  148. McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510
  149. Meijers BKI, 2010, NEPHROL DIAL TRANSPL, V25, P219, DOI 10.1093/ndt/gfp414
  150. Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109
  151. Merino A, 2012, NEPHROL DIAL TRANSPL, V27, P2907, DOI 10.1093/ndt/gfr767
  152. Monteiro RMM, 2009, TRANSPL IMMUNOL, V21, P50, DOI 10.1016/j.trim.2009.02.003
  153. Motojima M, 2003, KIDNEY INT, V63, P1671, DOI 10.1046/j.1523-1755.2003.00906.x
  154. Mulay SR, 2017, NAT REV NEPHROL, V13, P226, DOI 10.1038/nrneph.2017.10
  155. Nakabayashi I, 2011, NEPHROL DIAL TRANSPL, V26, P1094, DOI 10.1093/ndt/gfq624
  156. Nataraj C, 1999, J CLIN INVEST, V104, P1693, DOI 10.1172/JCI7451
  157. Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680
  158. Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
  159. Nogueira E, 2010, INT IMMUNOPHARMACOL, V10, P1481, DOI 10.1016/j.intimp.2010.09.005
  160. OGRYZLO MA, 1966, CAN MED ASSOC J, V95, P1120
  161. Okabe C, 2013, AM J PHYSIOL-RENAL, V305, pF155, DOI 10.1152/ajprenal.00491.2012
  162. Ordaz-Medina SM, 2010, ASAIO J, V56, P37, DOI 10.1097/MAT.0b013e3181c1d830
  163. Parikh CR, 2006, AM J TRANSPLANT, V6, P1639, DOI 10.1111/j.1600-6143.2006.01352.x
  164. Parish IA, 2009, CURR OPIN IMMUNOL, V21, P291, DOI 10.1016/j.coi.2009.05.008
  165. Patel RM, 2013, CLIN PERINATOL, V40, P11, DOI 10.1016/j.clp.2012.12.002
  166. Pavan M, 2016, MINERVA UROL NEFROL, V68, P222
  167. Peters CD, 2017, HEMODIAL INT, V21, P47, DOI 10.1111/hdi.12436
  168. Pinero-Lambea C, 2015, CURR OPIN BIOTECH, V35, P94, DOI 10.1016/j.copbio.2015.05.004
  169. Poesen R, 2016, J AM SOC NEPHROL, V27, P1389, DOI 10.1681/ASN.2015030279
  170. Prakash S, 1996, NAT MED, V2, P883, DOI 10.1038/nm0896-883
  171. Pulskens WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085775
  172. Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722
  173. Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525
  174. Ranganathan N, 2006, ASAIO J, V52, P70, DOI 10.1097/01.mat.0000191345.45735.00
  175. Ranganathan N, 2005, THESCIENTIFICWORLDJO, V5, P652, DOI 10.1100/tsw.2005.86
  176. Ranganathan N, 2010, ADV THER, V27, P634, DOI [10.1007/s12325-010-0059-9, 10.1007/s12325-010-0056-z]
  177. Raup-Konsavage WM, 2018, KIDNEY INT, V93, P365, DOI 10.1016/j.kint.2017.08.014
  178. Rice JL, 2015, LUNG, V193, P893, DOI 10.1007/s00408-015-9792-9
  179. Richter CK, 2015, ADV NUTR, V6, P712, DOI 10.3945/an.115.009654
  180. Rook GA, 2013, P NATL ACAD SCI USA, V110, P18360, DOI 10.1073/pnas.1313731110
  181. Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42
  182. Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430
  183. Rossi M, 2016, CLIN J AM SOC NEPHRO, V11, P223, DOI 10.2215/CJN.05240515
  184. Rostron AJ, 2010, TRANSPLANTATION, V90, P732, DOI 10.1097/TP.0b013e3181eefe02
  185. Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8
  186. Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265
  187. Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430
  188. Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188
  189. Sanchez-Villegas A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0428-y
  190. Sanders SA, 1997, EUR J BIOCHEM, V245, P541, DOI 10.1111/j.1432-1033.1997.00541.x
  191. Saran R, 2018, AM J KIDNEY DIS, V71, pS1, DOI 10.1053/j.ajkd.2018.01.002
  192. Saran R, 2017, AM J KIDNEY DIS, V69, DOI 10.1053/j.ajkd.2016.12.004
  193. SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181
  194. Shan Y, 2010, NEPHROLOGY, V15, P354, DOI 10.1111/j.1440-1797.2009.01249.x
  195. Shenderov Boris A., 2013, Microbial Ecology in Health and Disease, V24, DOI 10.3402/mehd.v24i0.20399
  196. Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252
  197. Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330
  198. Shigeoka AA, 2010, J IMMUNOL, V184, P2297, DOI 10.4049/jimmunol.0903065
  199. SHIMADA K, 1978, J BIOCHEM-TOKYO, V84, P1013, DOI 10.1093/oxfordjournals.jbchem.a132183
  200. Silk DBA, 2009, ALIMENT PHARM THER, V29, P508, DOI 10.1111/j.1365-2036.2008.03911.x
  201. Simenhoff ML, 1996, MINER ELECTROL METAB, V22, P92
  202. Singbartl K, 2019, SEMIN NEPHROL, V39, P96, DOI 10.1016/j.semnephrol.2018.10.007
  203. Singh R, 2014, CLIN MICROBIOL INFEC, V20, pO977, DOI 10.1111/1469-0691.12683
  204. Sirich TL, 2014, CLIN J AM SOC NEPHRO, V9, P1603, DOI 10.2215/CJN.00490114
  205. Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006
  206. Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
  207. Snelgrove SL, 2017, TRANSPLANTATION, V101, P1013, DOI 10.1097/TP.0000000000001427
  208. So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344
  209. Sola R, 2007, AM J CLIN NUTR, V85, P1157
  210. Soty M, 2015, MOL METAB, V4, P106, DOI 10.1016/j.molmet.2014.12.009
  211. Stamatiades EG, 2016, CELL, V166, P991, DOI 10.1016/j.cell.2016.06.058
  212. Stenvinkel P, 1999, J INTERN MED, V246, P503, DOI 10.1046/j.1365-2796.1999.00560.x
  213. Stubbs JR, 2016, J AM SOC NEPHROL, V27, P305, DOI 10.1681/ASN.2014111063
  214. Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4
  215. Tadagavadi RK, 2010, J AM SOC NEPHROL, V21, P53, DOI 10.1681/ASN.2009040407
  216. Takayama F, 2003, AM J KIDNEY DIS, V41, pS142, DOI 10.1053/ajkd.2003.50104
  217. Taki K, 2005, J RENAL NUTR, V15, P77, DOI 10.1053/j.jrn.2004.09.028
  218. Takiishi T, 2012, J CLIN INVEST, V122, P1717, DOI 10.1172/JCI60530
  219. Tan YQ, 2012, COLD REG SCI TECHNOL, V70, P107, DOI 10.1016/j.coldregions.2011.08.006
  220. Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360
  221. Teles F, 2009, KIDNEY INT, V75, P72, DOI 10.1038/ki.2008.528
  222. Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320
  223. THORNTON MA, 1989, AM J PATHOL, V135, P509
  224. Tittel AP, 2011, J AM SOC NEPHROL, V22, P1435, DOI 10.1681/ASN.2010101072
  225. Trentin-Sonoda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139350
  226. Usami M, 2008, NUTR RES, V28, P321, DOI 10.1016/j.nutres.2008.02.012
  227. Valette X, 2013, INTENS CARE MED, V39, P857, DOI 10.1007/s00134-013-2826-y
  228. Vandenbroucke K, 2010, MUCOSAL IMMUNOL, V3, P49, DOI 10.1038/mi.2009.116
  229. Vandeputte D, 2017, GUT, V66, P1968, DOI 10.1136/gutjnl-2016-313271
  230. Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881
  231. Vaziri ND, 2013, AM J NEPHROL, V38, P99, DOI 10.1159/000353764
  232. Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345
  233. Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010
  234. Verzola D, 2014, KIDNEY INT, V86, P1229, DOI 10.1038/ki.2014.116
  235. Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009
  236. Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
  237. Wanders D, 2012, BIOCHEM BIOPH RES CO, V425, P278, DOI 10.1016/j.bbrc.2012.07.082
  238. Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4
  239. Wang IK, 2012, APPL ENVIRON MICROB, V78, P1107, DOI 10.1128/AEM.05605-11
  240. Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614
  241. Wang RF, 2019, NEPHROL DIAL TRANSPL, V34, P1853, DOI 10.1093/ndt/gfy385
  242. Wang YH, 2017, IMMUNOL LETT, V183, P73, DOI 10.1016/j.imlet.2017.01.011
  243. Watanabe H, 2013, KIDNEY INT, V83, P582, DOI 10.1038/ki.2012.448
  244. Watson C, 1899, Br Med J, V1, P205
  245. Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037
  246. Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
  247. Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010
  248. Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008
  249. Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048
  250. Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
  251. Xiao J, 2015, INT J MOL MED, V35, P1347, DOI 10.3892/ijmm.2015.2148
  252. Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
  253. Yoshifuji A, 2016, NEPHROL DIAL TRANSPL, V31, P401, DOI 10.1093/ndt/gfv353
  254. Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982
  255. Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774
  256. Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212
  257. Zoccali C, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.52